Santhera Pharmaceuticals Holding AG (SPHDF)
19.79
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Santhera Pharmaceuticals Research and Development Expense (TTM) : 26.72M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | 26.72M |
| June 30, 2025 | 28.12M |
| December 31, 2024 | 30.04M |
| June 30, 2024 | 25.56M |
| December 31, 2023 | 20.77M |
| June 30, 2023 | 24.84M |
| December 31, 2022 | 32.02M |
| June 30, 2022 | 35.38M |
| December 31, 2021 | 32.49M |
| June 30, 2021 | 33.10M |
| December 31, 2020 | 36.45M |
| June 30, 2020 | 40.50M |
| December 31, 2019 | 41.52M |
| June 30, 2019 | 38.91M |
| December 31, 2018 | 39.08M |
| June 30, 2018 | 34.73M |
| December 31, 2017 | 27.02M |
| June 30, 2017 | 21.46M |
| December 31, 2016 | 17.94M |
| Date | Value |
|---|---|
| June 30, 2016 | 14.89M |
| December 31, 2015 | 9.665M |
| June 30, 2015 | 7.050M |
| December 31, 2014 | 6.174M |
| June 30, 2014 | 3.840M |
| December 31, 2013 | 4.480M |
| June 30, 2013 | 8.398M |
| December 31, 2012 | 9.396M |
| June 30, 2012 | 14.15M |
| December 31, 2011 | 20.45M |
| June 30, 2011 | 17.81M |
| December 31, 2010 | 15.06M |
| June 30, 2010 | 21.40M |
| December 31, 2009 | 29.00M |
| June 30, 2009 | 29.06M |
| December 31, 2008 | 29.10M |
| June 30, 2008 | 25.76M |
| December 31, 2007 | 19.49M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Basilea Pharmaceutica AG | 153.18M |
| BeOne Medicines Ltd. | 2.220B |
| AC Immune SA | 57.87M |
| CRISPR Therapeutics AG | 263.69M |
| Idorsia Ltd. | 121.31M |